Valuation Virbac

Stocks

Market Closed - Euronext Paris 16:55:00 13/11/2026 GMT			After hours 20:33:11
354.50 ^EUR	-0.84%		355.00	+0.14%

11-10	Virbac retains TP ICAP Midcap's confidence
10-20	Virbac: A well-done Q3 validates underlying quality

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,584	1,927	3,035	2,651	2,995	2,996	-	-
Change	-	-46.24%	57.52%	-12.67%	13%	0.05%	-	-
Enterprise Value (EV) ¹	3,510	1,848	2,983	2,819	3,168	3,105	3,061	2,984
Change	-	-47.37%	61.45%	-5.49%	12.37%	-1.99%	-1.42%	-2.51%
P/E	31.7x	15.8x	25x	18.3x	19.9x	17.3x	15.6x	14.2x
PBR	4.95x	2.29x	3.34x	2.54x	2.66x	2.31x	2.04x	1.76x
PEG	-	2.06x	-72.15x	0.9x	5.23x	1.2x	1.4x	1.47x
Capitalization / Revenue	3.37x	1.58x	2.43x	1.9x	2.04x	1.93x	1.82x	1.72x
EV / Revenue	3.3x	1.52x	2.39x	2.02x	2.16x	2x	1.85x	1.71x
EV / EBITDA	16.3x	8.27x	12.8x	9.96x	10.9x	9.71x	8.65x	7.74x
EV / EBIT	20.8x	10.1x	16.1x	12.4x	13.8x	12x	10.6x	9.51x
EV / FCF	36.5x	40.7x	50.8x	22.8x	29.7x	35.2x	25.2x	20x
FCF Yield	2.74%	2.46%	1.97%	4.39%	3.37%	2.84%	3.98%	5%
Dividend per Share ²	1.25	1.32	1.32	1.45	1.45	1.678	1.881	2.058
Rate of return	0.29%	0.58%	0.37%	0.46%	0.41%	0.47%	0.53%	0.58%
EPS ²	13.4	14.43	14.38	17.34	18	20.68	22.93	25.14
Distribution rate	9.33%	9.15%	9.18%	8.36%	8.06%	8.11%	8.21%	8.19%
Net sales ¹	1,064	1,216	1,247	1,397	1,465	1,555	1,651	1,742
EBITDA ¹	215.1	223.4	232.8	283	289.5	319.6	354	385.7
EBIT ¹	168.9	182.8	184.9	227.5	229.7	259	287.4	313.9
Net income ¹	113.2	122	121.3	145.3	150.9	173.2	192.9	211.5
Net Debt ¹	-73.83	-79.36	-52.36	168.5	172.8	108.2	64.2	-12.7
Reference price ²	424.50	228.00	359.50	316.50	357.50	357.50	357.50	357.50
Nbr of stocks (in thousands)	8,443	8,451	8,443	8,375	8,378	8,382	-	-
Announcement Date	22/03/22	23/03/23	19/03/24	13/03/25	17/03/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
VIRBAC	17.29x	2x	9.71x	0.47%	3.31B
ELI LILLY AND COMPANY	41.92x	14.14x	29.98x	0.48%	1,271B
JOHNSON & JOHNSON	41.5x	6.96x	19.58x	1.88%	683B
ABBVIE INC.	37.54x	8.61x	17.78x	2.34%	520B
ROCHE HOLDING AG	21.85x	5.3x	13.27x	2.47%	389B
MERCK & CO., INC.	104.3x	5.95x	25.36x	2.31%	362B
NOVARTIS AG	24.13x	5.85x	14.24x	2.72%	304B
ASTRAZENECA PLC	24.18x	4.84x	13.59x	1.81%	286B
AMGEN INC.	24.11x	7.4x	13.59x	2.16%	253B
GILEAD SCIENCES, INC.	-39.46x	7.31x	46.04x	1.97%	208B
Average	29.74x	6.84x	20.31x	1.86%	428B
Weighted average by Cap.	37.30x	8.88x	22.51x	1.68%